LEP and neoplasm: It is generally indicated that TNF-α promotes progression of RCC by enhancing tumor invasion and epithelial-mesenchymal transition and that lower serum adiponectin levels and higher serum leptin levels are associated with higher aggressiveness of RCC20–23.